🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Surgical Evacuation Of Spontaneous Intracerebral Hematoma: Clinical Outcomes and Prognostic Factors

RecruitingNAAges 20 Years - 70 YearsAllSohag University
NCT06816641 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of this study is to assess the safety and efficacy of surgical evacuation of spontaneous intracerebral hemorrhage.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * • Patients with radiological findings of ICH. * Age group 20-70 years. Exclusion Criteria: * • Traumatic ICH or ruptured aneurysm or AVM or brain tumor. * Postoperative cranial surgery ICH. * Secondary hydrocephalus. * Patients with other comorbidities e.g., Liver cell failure and renal cell failure. * Patients with bleeding disorders. * Patients who are regular on anticoagulant or antiplatelet therapy. * Small sized ICH\< 30 ml. * GCS less than 6 preoperatively.
💊

What it tests

  • Surgical Evacuation of Intracerebral Hemorrhage
📍

Where

1 site
Sohag University hospitals
Sohag, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy